ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

NBRV Nabriva Therapeutics PLC

1,42
0,00 (0,00%)
20 Mai 2024 - Fermé
Retardé de 15 minutes
Quarter End Mar 2021Juin 2021Sept 2021Déc 2021Mar 2022Juin 2022Sept 2022Déc 2022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 2,53M8,59M8,99M9,25M8,02M9,41M9,51M10,57M
Revenu d'exploitation -13,45M-11,03M-10,68M-12,89M-11,56M-10,18M-10,85M-22,33M
Revenu avant impôt -13,79M-11,15M-10,9M-13,12M-11,47M-10,69M-10,99M-22,47M
Revenu net -13,98M-11,75M-10,65M-13,06M-11,82M-11,07M-11,51M-22,78M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT -13,57M-10,91M-10,68M-12,89M-11,25M-10,18M-10,85M-22,33M
EBITDA -13,18M-10,83M-10,6M-12,81M-11,48M-10,11M-10,81M-22,31M
Fin d'année 31 Décembre 2022 20152016201720182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 3,77M6,54M5,81M9,66M9,7M6,21M29,36M37,51M
Revenu d'exploitation -27,76M-54,99M-73,28M-114,65M-79,27M-64,94M-48,06M-54,92M
Revenu avant impôt -47,41M-55,56M-73M-114,73M-82,66M-69,35M-48,96M-55,62M
Revenu net -46,96M-54,89M-74,36M-114,78M-82,76M-69,48M-49,45M-57,19M
Dividendes privilégiés 00000000
Résultat de base par action -22.195-20.18-2.026-1.713-0.875-3.296-0.872-17.865
EBIT -28,16M-54,99M-73,28M-114,65M-79,27M-67,7M-48,06M-54,92M
EBITDA -27,61M-54,76M-72,84M-114,14M-78,5M-64,12M-47,42M-54,7M

Dernières Valeurs Consultées

Delayed Upgrade Clock